AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tacro A 0.1% Ointment

Prescription Icon
Prescription Required

Marketer

Aryan Pharmaceuticals

Salt Composition

Tacrolimus (0.1% w/w)

Overview Tacro A 0.1% Ointment

Eczema (atopic dermatitis) is treated with Tacro A 0.1% Ointment, which reduces inflammation (skin redness and swelling) by modulating the activity of specific immune cells. This soothes itching and clears atopic dermatitis rashes. Apply Tacro A 0.1% Ointment topically, 2–4 times daily to affected skin, or as your physician directs. Gently and evenly rub the ointment into the skin. Avoid over-application and avoid bandaging or covering the treated area. Consult your doctor if there's no improvement after a fortnight or if your condition worsens. Common side effects include redness, headache, folliculitis, and application site reactions such as burning, irritation, itching, and redness. Unless medically necessary, this ointment is generally not advised during pregnancy or breastfeeding.

Uses of Tacro A 0.1% Ointment

Managing atopic dermatitis

Major Benefits of Tacro A 0.1% Ointment:

Apply this medication solely to the skin's surface. Follow your physician's instructions precisely regarding dosage and treatment length. Always consult the product label for application guidelines prior to use. Ensure the affected area is clean and dry before gently rubbing in the cream.

Common Side effects of Tacro A 0.1% Ointment:

  • Application site reactions (burning, irritation, itching and redness)
  • Headache
  • Hair follicle inflammation

How to use Tacro A 0.1% Ointment:

Apply this medication topically only. Follow your physician's instructions precisely regarding dosage and treatment length. Always consult the product label for application details prior to use. Ensure the affected skin is clean and dry before applying the ointment with a gentle massaging motion.

How Tacro A 0.1% Ointment works:

Tacrolimus 0.1% ointment, an immunosuppressant topical medication, reduces skin inflammation by inhibiting the action of immune cells responsible for redness and swelling. This alleviates itching and improves the appearance of rashes associated with atopic dermatitis.

SAFETY ADVICE

AlcoholAlcoholNone

No known drug interactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Tacro A 0.1% Ointment during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Topical Tacrolimus 0.1% ointment application during lactation appears unlikely to pose a substantial risk to the infant, based on the currently available, albeit limited, clinical data in breastfeeding mothers.

DrivingDrivingNone

No known drug interactions.

KidneyKidneyNone

No drug interactions identified.

LiverLiverNone

No known drug interactions.

What if you forget to take Tacro A 0.1% Ointment :

Should you forget a dose of Tacro A 0.1% Ointment, apply it immediately. Nevertheless, if your next scheduled application is imminent, omit the missed dose and resume your usual dosing regimen.

Facts to Know About Tacro A 0.1% Ointment

LabelValue
Type of Compound Large-ring lactone antibiotics
Potential for Dependence None.
Type of Medication Cancer therapies
Mechanism of Action Drugs suppressing the immune system: Calcineurin inhibitors.

FAQs on Tacro A 0.1% Ointment

Tacrolimus 0.1% ointment is an immunomodulatory medication that primarily suppresses immune system activity. It's indicated for treating moderate to severe atopic dermatitis in adults who have not responded to, or who experience adverse reactions from, steroid treatments. Atopic dermatitis involves an overactive immune response in the skin, resulting in inflammation manifested as itching, redness, and dryness. Tacrolimus 0.1% ointment modifies this aberrant immune reaction, consequently reducing skin inflammation and pruritus.
Topical application of Tacro A 0.1% Ointment can induce local skin reactions. These may include irritation, burning, and itching, generally mild to moderate and typically subsiding within seven days. Erythema, warmth, pain, paresthesia, and rash are also frequently reported at the application site. Treatment is associated with a heightened risk of folliculitis, herpes labialis, acne, and disseminated herpes simplex virus infection.
Tacro A 0.1% Ointment offers a safe and effective short-term topical treatment for atopic dermatitis, exhibiting superior safety compared to other immunosuppressants. Minimal systemic absorption following cutaneous application results in fewer adverse effects than oral administration.
Tacrolimus 0.1% ointment is not a controlled substance and carries no risk of misuse. Controlled substances, by definition, possess abuse potential, requiring authorization from both a physician and regulatory authorities for dispensing.
Prolonged application of Tacrolimus 0.1% ointment is associated with a heightened lymphoma risk (a type of lymph node tumor). Limited research indicates a link between Tacrolimus 0.1% ointment, or comparable topical treatments, and the development of skin cancer or lymphoma in a small subset of patients. Seek medical advice if Tacrolimus 0.1% ointment use exceeds six weeks, or if your eczema symptoms remain unchanged or worsen despite treatment.
Tacrolimus 0.1% ointment is non-steroidal. This medication modifies immune system function and treats eczema, particularly atopic dermatitis. Unlike steroids, Tacrolimus 0.1% ointment avoids side effects such as skin thinning.
Tacro A 0.1% Ointment
460
MRP 560
17% off